AMORPHIS PHARMA DEVELOPMENT SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

Key data

Status

Active

KRS number

REGON

NIP/VAT code

VAT registration date

04/01/2019

VAT status

Active

Bankruptcy proceedings

No proceedings

AMORPHIS PHARMA DEVELOPMENT SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

Contacts

Registered address

See on map

Website

Not calculated

Highest reliabilityLowest reliability

Reliability

A - Highest

B - High

C - Average

D - Low

E - Lowest

Prescore cannot be calculated because the company delayed submission of financial statements.

Incorporation date

30/11/2018

Share capital

5,850.00 PLN

Primary activity

Manufacture of basic pharmaceutical products (21.10.Z - PKD 2007)

Representatives

Representatives rights

DO SKŁADANIA OŚWIADCZEŃ W ZAKRESIE PRAW I OBOWIĄZKÓW MAJĄTKOWYCH SPÓŁKI SĄ UPOWAŻNIENI: A) W PRZYPADKU ZARZĄDU WIELOOSOBOWEGO- DWÓCH CZŁONKÓW ZARZĄDU DZIAŁAJĄCYCH ŁĄCZNIE, W TYM PREZES ZARZĄDU O ILE ZOSTANIE POWOŁANY B) W PRZYPADKU ZARZĄDU JEDNOOSOBOWO- CZŁONEK ZARZĄDU SAMODZIELNIE

Representatives

No representatives

Business linkages

Price: zł63.00
Premium users: 1.00 credit

Financial report (Okredo)

Price: zł22.00
Premium users: 1.00 credit

People

Representatives

Person	Title
-	-

Persons with Significant Control

This information is available in our reports and to subscription users.

Financial ratios

Net Profit (zł)

-9,100

Net Profit (zł)

-9,100

Financial report (Okredo)

Price: zł22.00
Premium users: 1.00 credit

Indicator
Turnover (zł)
Profit before tax (zł)
Net Profit (zł)
Working capital requirement (%) The working capital requirement indicator shows how much funds a company needs to develop and maintain a business.
Liquidity ratio liquidityRatio
Net profitability (%) This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales.
Equity (zł)
Current liabilities (zł)
Non current liabilities (zł)
Non-current Assets (zł)

2021
312,188
153
153
0.95
14.42
0.05
520,480
21,979
0
847,587

2022
64,112
15,359
15,359
2.53
50.31
23.96
456,148
3,289
0
881,699

2023
136,675
-9,100
-9,100
0.25
789.72
-6.66
457,864
43
0
998,399

2023
136,675
-9,100
-9,100
0.25
789.72
-6.66
457,864
43
0
998,399

Turnover (zł)

2023

Turnover (zł)

136,675 zł113 % *

Profit before tax (zł)

-9,100 zł-159 % *

Net Profit (zł)

-9,100 zł-159 % *

Working capital requirement (%)

0.25 -90.12 % *

Liquidity ratio

789.72 1,469.71 % *

Net profitability (%)

-6.66 %-127.80 % *

Equity (zł)

457,864 zł0 % *

Current liabilities (zł)

43 zł-99 % *

Non current liabilities (zł)

0 zł- *

Non-current Assets (zł)

998,399 zł13 % *

*over the last year starting selected period

Credit history

No. of unpaid debts

Largest debt

Amount of unpaid debts

€0.00

Oldest open debt

No. of unpaid debts

Largest debt

Amount of unpaid debts

€0.00

Oldest open debt

Credit report

Price: 1.00 credit

Unpaid debts

Creditor/Data source	Debt amount	Debt date	Debt type
-	-	-	-

Debt payment history

Creditor/Data source	Debt amount	Debt date	Payment date	Debt type
-	-	-	-	-

Documents

AMORPHIS PHARMA DEVELOPMENT SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ Documents

Date	Description
28/06/2024	OD 01.01.2023 DO 31.12.2023
21/06/2023	OD 01.01.2022 DO 31.12.2022
29/09/2022	OD 01.01.2021 DO 31.12.2021
30/06/2021	OD 01.01.2020 DO 31.12.2020
23/06/2020	OD 28.06.2018 DO 31.12.2019